Trials / Completed
CompletedNCT04387617
A Study to Assess the Effect of Cannabidiol Oil on Pain After Ureteroscopy for Kidney Stones
Effect of Cannabidiol Oil on Postoperative Pain After Ureteroscopy for Urinary Calculi
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if CBD oil has any effect on decreasing postoperative pain control following ureteroscopy for urinary stone disease, and to determine if CBD oil has any effect in decreasing the amount of postoperative opioids (commonly used drug) used by patients after undergoing ureteroscopy for urinary stone disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cannabidiol | The product is a liquid formulation that will be prescribed at a dosage of 20 mg per day for a total of 3 days. |
| DRUG | Placebo | The product is a liquid formulation placebo that will be prescribed at an equivalent volume as active drug for 3 days |
Timeline
- Start date
- 2021-02-15
- Primary completion
- 2022-01-31
- Completion
- 2022-01-31
- First posted
- 2020-05-14
- Last updated
- 2023-01-18
- Results posted
- 2023-01-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04387617. Inclusion in this directory is not an endorsement.